company background image

Dr. Wu Skincare TPEX:6523 Stock Report

Last Price


Market Cap







11 Aug, 2022


Company Financials +
6523 fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance3/6
Financial Health6/6

6523 Stock Overview

Dr. Wu Skincare Co., Ltd. develops and sells skincare and cosmetics products in Taiwan and internationally.

Dr. Wu Skincare Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Dr. Wu Skincare
Historical stock prices
Current Share PriceNT$81.60
52 Week HighNT$152.50
52 Week LowNT$69.40
1 Month Change2.00%
3 Month Change2.13%
1 Year Change11.63%
3 Year Change32.47%
5 Year Change-37.23%
Change since IPO-55.49%

Recent News & Updates

Shareholder Returns

6523TW Personal ProductsTW Market

Return vs Industry: 6523 exceeded the TW Personal Products industry which returned -17.6% over the past year.

Return vs Market: 6523 exceeded the TW Market which returned -13.2% over the past year.

Price Volatility

Is 6523's price volatile compared to industry and market?
6523 volatility
6523 Average Weekly Movement4.2%
Personal Products Industry Average Movement4.6%
Market Average Movement5.1%
10% most volatile stocks in TW Market8.4%
10% least volatile stocks in TW Market2.5%

Stable Share Price: 6523 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: 6523's weekly volatility (4%) has been stable over the past year.

About the Company

2003n/aEric Wu

Dr. Wu Skincare Co., Ltd. develops and sells skincare and cosmetics products in Taiwan and internationally. The company offers cleansers, masks, toners, serums, lotion/cream/gel, UV/DD creams, and eye care products, as well as makeup and body products. It also provides products for acne and pores, blackheads, dry skin, signs of aging, dull and spotty skin, sensitive skin, whitening, and emergency care.

Dr. Wu Skincare Fundamentals Summary

How do Dr. Wu Skincare's earnings and revenue compare to its market cap?
6523 fundamental statistics
Market CapNT$3.68b
Earnings (TTM)NT$322.54m
Revenue (TTM)NT$1.13b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
6523 income statement (TTM)
Cost of RevenueNT$415.45m
Gross ProfitNT$710.43m
Other ExpensesNT$387.89m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date


Earnings per share (EPS)7.16
Gross Margin63.10%
Net Profit Margin28.65%
Debt/Equity Ratio0%

How did 6523 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
We’ve recently updated our valuation analysis.


Is 6523 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 4/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6523?

Other financial metrics that can be useful for relative valuation.

6523 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2x
Enterprise Value/EBITDA5.6x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 6523's PE Ratio compare to its peers?

6523 PE Ratio vs Peers
The above table shows the PE ratio for 6523 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average19x
4190 Jourdeness Group
1783 Maxigen Biotech
8480 Taisun Int'l (Holding)
1731 Maywufa
6523 Dr. Wu Skincare

Price-To-Earnings vs Peers: 6523 is good value based on its Price-To-Earnings Ratio (11.4x) compared to the peer average (19x).

Price to Earnings Ratio vs Industry

How does 6523's PE Ratio compare vs other companies in the Asian Personal Products Industry?

Price-To-Earnings vs Industry: 6523 is good value based on its Price-To-Earnings Ratio (11.4x) compared to the TW Personal Products industry average (19.2x)

Price to Earnings Ratio vs Fair Ratio

What is 6523's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6523 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio11.4x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 6523's Price-To-Earnings Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of 6523 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 6523 (NT$81.6) is trading below our estimate of fair value (NT$141.06)

Significantly Below Fair Value: 6523 is trading below fair value by more than 20%.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Future Growth

How is Dr. Wu Skincare forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score


Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted Household industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Dr. Wu Skincare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Discover growth companies

  • Examine whether Dr. Wu Skincare is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.

Past Performance

How has Dr. Wu Skincare performed over the past 5 years?

Past Performance Score


Past Performance Score 3/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 6523 has high quality earnings.

Growing Profit Margin: 6523's current net profit margins (28.6%) are lower than last year (84.9%).

Past Earnings Growth Analysis

Earnings Trend: 6523's earnings have grown significantly by 32.8% per year over the past 5 years.

Accelerating Growth: 6523's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 6523 had negative earnings growth (-53.6%) over the past year, making it difficult to compare to the Personal Products industry average (-29.7%).

Return on Equity

High ROE: 6523's Return on Equity (20.8%) is considered high.

Discover strong past performing companies

Financial Health

How is Dr. Wu Skincare's financial position?

Financial Health Score


Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 6523's short term assets (NT$1.7B) exceed its short term liabilities (NT$302.2M).

Long Term Liabilities: 6523's short term assets (NT$1.7B) exceed its long term liabilities (NT$15.9M).

Debt to Equity History and Analysis

Debt Level: 6523 is debt free.

Reducing Debt: 6523 had no debt 5 years ago.

Debt Coverage: 6523 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 6523 has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies


What is Dr. Wu Skincare current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 2/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 6523's dividend (13.75%) is higher than the bottom 25% of dividend payers in the TW market (2.53%).

High Dividend: 6523's dividend (13.75%) is in the top 25% of dividend payers in the TW market (6.58%)

Stability and Growth of Payments

Stable Dividend: 6523 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 6523's dividend payments have increased, but the company has only paid a dividend for 6 years.

Earnings Payout to Shareholders

Earnings Coverage: With its high payout ratio (156.7%), 6523's dividend payments are not well covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: With its high cash payout ratio (169.1%), 6523's dividend payments are not well covered by cash flows.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Eric Wu

no data


Dr. Yi-Ju Wu, also known as Eric, is a Founder of Dr. Wu Skincare Co., Ltd and serves as its Chairman and has been its Director since February 27, 2003 and serves as its Chief Executive Officer.

Leadership Team

Experienced Management: 6523's management team is considered experienced (2.3 years average tenure).

Board Members

Experienced Board: 6523's board of directors are considered experienced (4.3 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

Dr. Wu Skincare Co., Ltd.'s employee growth, exchange listings and data sources

Key Information

  • Name: Dr. Wu Skincare Co., Ltd.
  • Ticker: 6523
  • Exchange: TPEX
  • Founded: 2003
  • Industry: Personal Products
  • Sector: Household
  • Implied Market Cap: NT$3.676b
  • Shares outstanding: 45.05m
  • Website:


  • Dr. Wu Skincare Co., Ltd.
  • No.70, Nanjing East Road
  • 13th Floor
  • Taipei
  • 104
  • Taiwan


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/11 00:00
End of Day Share Price2022/08/10 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.